Sier CFM

Citado por

	Total	Desde 2019
Citas	8573	2662
Índice h	53	28
Índice i10	105	67

660

330

165

495

199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202425 60 72 98 124 111 122 105 216 183 166 216 156 239 283 234 230 336 402 357 442 418 424 393 414 349 497 658 464 540 154

Acceso público

Ver todo

45 artículos

1 artículo

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Peter J.K. KuppenLeiden University Medical Center, Dept. of SurgeryDirección de correo verificada de lumc.nl
Lukas HawinkelsAssociate professor/Head of research laboratory Gastroenterology, Leiden University Medical CenterDirección de correo verificada de LUMC.nl
Roeland HanemaaijerTNO Metabolic Health ResearchDirección de correo verificada de tno.nl
JH VerheijenQuickZyme Biosciences Leiden The NetherlandsDirección de correo verificada de ememar.nl
M.C. BoonstraLeids Universitair Medische CentrumDirección de correo verificada de lumc.nl
Nicolai SideniusDirección de correo verificada de ifom.eu
J van kriekenhoogleraar pathologie, UMC St RadboudDirección de correo verificada de radboudumc.nl
I.B. SchipperDirección de correo verificada de lumc.nl
Peter ten DijkeDirección de correo verificada de lumc.nl
B.A.BonsingDirección de correo verificada de lumc.nl
Paul QuaxLeiden University Medical Center, the NetherlandsDirección de correo verificada de lumc.nl
Susanna W.L. de GeusBoston University School of MedicineDirección de correo verificada de bmc.org
Sven MieogOncological surgeon (hepatobiliary and pancreatic surgery)Dirección de correo verificada de lumc.nl
James C H HardwickLeiden University Medical Center, Leiden, The NetherlandsDirección de correo verificada de lumc.nl
Rutger-Jan Swijnenburg, MD, PhDHepato-Pancreato-Biliary Surgeon, Amsterdam UMCDirección de correo verificada de amsterdamumc.nl
Ruben HouvastPhD candidate, Department of Surgery, Leiden University Medical Center, NetherlandsDirección de correo verificada de lumc.nl
Lioe-Fee de Geus-OeiProfessor in Radiology, with an emphasis on Nuclear Medicine at Leiden University Medical Center and Professor in Molecular Imaging, innovation and translation at the University of Twente, The NetherlandsDirección de correo verificada de lumc.nl
Andrea MarianiMayo ClinicDirección de correo verificada de mayo.edu
Jan LindemanLeiden University Medical CenterDirección de correo verificada de lumc.nl
Stijn Keereweer, MD, PhD, Associate...Otorhinolaryngologist, Head and Neck SurgeonDirección de correo verificada de erasmusmc.nl

Seguir

Sier CFM

Department of Surgery, Leiden University Medical Center, Netherlands

Dirección de correo verificada de lumc.nl

proteases tumor markers tumor targeting fluorescence guided surgery microenvironment


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma CFM Sier, F Kubben, S Ganesh, MM Heerding, G Griffioen, ... British journal of cancer 74 (3), 413-417, 1996	424	1996
Matrix metalloproteinase-14 (MT1-MMP)–mediated endoglin shedding inhibits tumor angiogenesis LJAC Hawinkels, P Kuiper, E Wiercinska, HW Verspaget, Z Liu, E Pardali, ... Cancer research 70 (10), 4141-4150, 2010	360	2010
Use and efficacy of bone morphogenetic proteins in fracture healing SN Lissenberg-Thunnissen, DJJ de Gorter, CFM Sier, IB Schipper International orthopaedics 35, 1271-1280, 2011	343	2011
Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts L Hawinkels, M Paauwe, HW Verspaget, E Wiercinska, JM Van Der Zon, ... Oncogene 33 (1), 97-107, 2014	313	2014
The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients CFM Sier, R Stephens, J Bizik, A Mariani, M Bassan, N Pedersen, ... Cancer research 58 (9), 1843-1849, 1998	253	1998
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection N Sidenius, CFM Sier, H Ullum, BK Pedersen, AC Lepri, F Blasi, ... Blood, The Journal of the American Society of Hematology 96 (13), 4091-4095, 2000	250	2000
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis LJAC Hawinkels, K Zuidwijk, HW Verspaget, ESM de Jonge-Muller, ... European journal of cancer 44 (13), 1904-1913, 2008	243	2008
Urokinase receptor and colorectal cancer survival SJ Ganesh, CFM Sier, MM Heerding, G Griffioen, CBHW Lamers, ... The Lancet 344 (8919), 401-402, 1994	229	1994
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer S Ganesh, CFM Sier, G Griffioen, HJM Vloedgraven, A de Boer, ... Cancer Research 54 (15), 4065-4071, 1994	215	1994
Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer FJGM Kubben, CFM Sier, LJAC Hawinkels, H Tschesche, W van Duijn, ... European journal of cancer 43 (12), 1869-1876, 2007	193	2007
Increased mucosal matrix metalloproteinase-1,-2,-3 and-9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype MJW Meijer, MAC Mieremet-Ooms, AM Van Der Zon, W van Duijn, ... Digestive and Liver Disease 39 (8), 733-739, 2007	186	2007
Expression of matrix metalloproteinases-2 and-9 in intestinal tissue of patients with inflammatory bowel diseases Q Gao, MJW Meijer, FJGM Kubben, CFM Sier, L Kruidenier, W van Duijn, ... Digestive and liver disease 37 (8), 584-592, 2005	170	2005
Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo N Sidenius, CFM Sier, F Blasi FEBS letters 475 (1), 52-56, 2000	168	2000
Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer F Kubben, CFM Sier, MJW Meijer, M Van Den Berg, JJ Van Der Reijden, ... British Journal of Cancer 95 (6), 744-751, 2006	165	2006
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices P Koolwijk, N Sidenius, E Peters, CFM Sier, R Hanemaaijer, F Blasi, ... Blood, The Journal of the American Society of Hematology 97 (10), 3123-3131, 2001	165	2001
Endoglin expression on cancer-associated fibroblasts regulates invasion and stimulates colorectal cancer metastasis M Paauwe, MJA Schoonderwoerd, RFCP Helderman, TJ Harryvan, ... Clinical Cancer Research 24 (24), 6331-6344, 2018	159	2018
Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage D Gveric, R Hanemaaijer, J Newcombe, NA van Lent, CFM Sier, ... Brain 124 (10), 1978-1988, 2001	155	2001
Superoxide dismutases in relation to the overall survival of colorectal cancer patients AML Janssen, CB Bosman, CFM Sier, G Griffioen, F Kubben, C Lamers, ... British Journal of Cancer 78 (8), 1051-1057, 1998	141	1998
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer F Kubben, CFM Sier, W Van Duijn, G Griffioen, R Hanemaaijer, ... British journal of cancer 94 (7), 1035-1040, 2006	132	2006
Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy S Mustjoki, N Sidenius, CFM Sier, F Blasi, E Elonen, R Alitalo, A Vaheri Cancer research 60 (24), 7126-7132, 2000	132	2000

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores